Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma

Space Invaders

(2018) Justine Sinnaeve et al.   AMERICAN JOURNAL OF PATHOLOGY

Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma

(2017) Michael Ingrisch et al.   INVESTIGATIVE RADIOLOGY

Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation

(2017) Jason K. Molitoris et al.   JOURNAL OF NEURO-ONCOLOGY

Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum

(2017) Akshitkumar M. Mistry et al.   JOURNAL OF NEURO-ONCOLOGY

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients

(2017) Tae Hoon Roh et al.   MEDICINE

EPID-08. EPIDEMIOLOGY OF GERM CELL TUMORS IN THE CENTRAL NERVOUS SYSTEM

(2017) Haley Gittleman et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

(2017) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

(2017) James R. Perry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status

(2017) Chan Woo Wee et al.   RADIOTHERAPY AND ONCOLOGY

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era

(2017) Erica Hlavin Bell et al.   JAMA Oncology

Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy

(2017) Seo Hee Choi et al.   Scientific Reports

Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma

(2016) Andrew W. Smith et al.   JOURNAL OF NEURO-ONCOLOGY

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

(2016) Yan Michael Li et al.   JOURNAL OF NEUROSURGERY

Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features

(2016) Philipp Kickingereder et al.   RADIOLOGY

Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion

(2016) Tony Hsiang-Kuang Liang et al.   RADIOTHERAPY AND ONCOLOGY

Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors

(2016) Jeongshim Lee et al.   YONSEI MEDICAL JOURNAL

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Maximum Safe Resection of Glioblastoma Multiforme

(2014) Michel Lacroix et al.   JOURNAL OF CLINICAL ONCOLOGY

Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery

(2014) Nicholas F. Marko et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial

(2014) Olgun Elicin et al.   JOURNAL OF NEURO-ONCOLOGY

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

(2014) Remco J. Molenaar et al.   NEURO-ONCOLOGY

Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

(2012) Jacob G. Scott et al.   CANCER

Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells

(2012) Jian Chen et al.   CELL

MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated With Temozolomide-Based Chemoradiotherapy: A Single-Institution Study

(2012) Young Suk Kim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Relationship of glioblastoma multiforme to the subventricular zone is associated with survival

(2012) Nazia F. Jafri et al.   NEURO-ONCOLOGY

Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma

(2010) Jing Li et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

(2010) Albert Lai et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era

(2010) Anthony J. Paravati et al.   JOURNAL OF NEURO-ONCOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

How To Build and Interpret a Nomogram for Cancer Prognosis

(2008) Alexia Iasonos et al.   JOURNAL OF CLINICAL ONCOLOGY